BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6543907)

  • 21. Screening for malignant hyperthermia susceptibility.
    Anderson IL; Rawstron RE; Dunlop DJ
    N Z Med J; 1980 Jun; 91(661):417-9. PubMed ID: 6930029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Malignant hyperthermia].
    Glahn KP
    Ugeskr Laeger; 2003 Apr; 165(17):1763-8. PubMed ID: 12768904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of droperidol, haloperidol and ketamine on halothane, succinylcholine and caffeine contractures: implications for malignant hyperthermia.
    Fletcher JE; Rosenberg H; Lizzo FH
    Acta Anaesthesiol Scand; 1989 Apr; 33(3):187-92. PubMed ID: 2728821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Theophylline induces contractures in porcine skeletal muscle preparations with the disposition to malignant hyperthermia].
    Gerbershagen MU; Fiege M; Weisshorn R; Kolodzie K; Wappler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Mar; 39(3):147-52. PubMed ID: 15042504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the in vitro caffeine-halothane contracture test with the Ca-induced Ca release rate test in patients suspected of having malignant hyperthermia susceptibility.
    Oku S; Mukaida K; Nosaka S; Sai Y; Maehara Y; Yuge O
    J Anesth; 2000 Jan; 14(1):6-13. PubMed ID: 14564603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous EMG recordings and intraoperative electrical stimulation for identification and protection of cervical nerve roots during foraminal tumor surgery.
    Guo L; Quiñones-Hinojosa A; Yingling CD; Weinstein PR
    J Spinal Disord Tech; 2006 Feb; 19(1):37-42. PubMed ID: 16462217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant hyperthermia in the otology patient: the UCLA experience.
    Wackym PA; Blackwell KE
    Am J Otol; 1994 May; 15(3):371-5. PubMed ID: 8579142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ankle dorsiflexor twitch properties in malignant hyperthermia.
    Quinlan JG; Iaizzo PA; Lambert EH; Gronert GA
    Muscle Nerve; 1989 Feb; 12(2):119-25. PubMed ID: 2710144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Electrophysiologic investigations in a family with malignant hyperthermia (author's transl)].
    Mamoli B; Sporn B; Steinbereithner K; Dal-Bianco P
    Fortschr Neurol Psychiatr Grenzgeb; 1980 Jun; 48(6):314-23. PubMed ID: 6902689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Postoperative hyperthermic syndrome with a questionable relationship to malignant hyperthermia and the need for elucidating susceptibility].
    Plötz J
    Anaesthesist; 1986 Dec; 35(12):751-4. PubMed ID: 3826611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An association between certain congenital abnormalities and the malignant hyperthermia trait.
    Gericke GS; Isaacs H
    S Afr Med J; 1990 Jun; 77(11):570-4. PubMed ID: 2345883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of susceptibility to malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1974 May; 2(5913):245-7. PubMed ID: 4827071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Contracture responses of the muscle from a patient with malignant hyperthermia to drugs].
    Iwatsuki N; Koga Y; Amaha K
    Masui; 1984 Jul; 33(7):731-6. PubMed ID: 6502923
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of succinylcholine on middle component auditory evoked potentials.
    Harker LA; Hosick E; Voots RJ; Mendel MI
    Arch Otolaryngol; 1977 Mar; 103(3):133-7. PubMed ID: 836239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electromyographic studies on chlorsuccilin.
    Edelwein Z; Szymańska M; Kubicz A
    Mater Med Pol; 1972; 4(1):23-7. PubMed ID: 4664409
    [No Abstract]   [Full Text] [Related]  

  • 36. Malignant hyperthermia. Quick recognition and treatment to avoid death.
    Larew RE
    Postgrad Med; 1989 Jun; 85(8):117-8, 128-9. PubMed ID: 2726633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study of muscle relaxants using evoked electromyography. 5. Repetitive paired stimulation].
    Suzuki H; Shirato T; Kanayama T; Nakagawa H; Yazaki S
    Masui; 1974 Jun; 23(6):489-99. PubMed ID: 4472657
    [No Abstract]   [Full Text] [Related]  

  • 38. Electrocardiographic abnormalities associated with malignant hyperthermia susceptibility.
    Huckell VF; Staniloff HM; Britt BA; Morch JE
    J Electrocardiol; 1982 Apr; 15(2):137-41. PubMed ID: 7069330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Motor unit counting and the caffeine contracture test in malignant hyperthermia.
    Britt BA; McComas AJ; Endrenyi L; Kalow W
    Anesthesiology; 1977 Dec; 47(6):490-7. PubMed ID: 337855
    [No Abstract]   [Full Text] [Related]  

  • 40. Ambulatory laboratory investigations for malignant hyperthermia susceptible patients.
    Ellis FR
    Acta Anaesthesiol Belg; 1988; 39(3 Suppl 2):253-4. PubMed ID: 3176861
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.